drugset / Trial / NCT03705559
Opioid and Cannabinoid Interactions
Phase 1
Completed
10 enrolled
Shanna Babalonis, PhD
National Institute on Drug Abuse (NIDA) · collab
RandomizedSequentialDouble-blindBasic science
Summary
This study will examine the effects of doses of marijuana/placebo and doses of opioid/placebo, alone and in combination. The primary outcomes are related to pharmacodynamic measures (subjective ratings of drug liking and other abuse-related effects; physiological outcomes) to determine the interaction effects of these compounds.
Timeline
- Start
- 2019-06-21
- Primary completion
- 2024-02-15
- Completion
- 2024-02-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabis | Traditional medicine (herbal / TCM) | — | Inhaled |
| Subject | Oxycodone | Other / unclassified | — | Intranasal |